Steqeyma Ustekinumab Stba Injection 130mg/26ml - Origin: India

Steqeyma is used in children and adolescents aged 6 years and older with moderate to severe plaque psoriasis who are unable to tolerate phototherapy or other systemic therapies or where these treatments did not work. Psoriatic arthritis is an inflammatory disease of the joints, usually accompanied by psoriasis.

Key Features:-
Biosimilar to Stelara, targets IL-12 and IL-23 cytokines.
Used for moderate to severe Crohna s disease and ulcerative colitis.
Treats adults and pediatric patients 6 years and older.
Delivered as 130 mg in 26 mL single-dose vial for IV infusion.
Manufactured using recombinant DNA technology in CHO cells.
Sterile, preservative-free, pale yellow solution.
Administered via intravenous infusion, diluted before use.
Approved by FDA for chronic inflammatory diseases.
Requires healthcare professional administration with aseptic technique.